Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, Tsonaka R, MacLaren RE, Downes SM, Fauser S, Boon CJF, Hoyng CB. van Rijssen TJ, et al. Among authors: tsonaka r. Am J Ophthalmol. 2020 Aug;216:80-89. doi: 10.1016/j.ajo.2020.04.007. Epub 2020 Apr 11. Am J Ophthalmol. 2020. PMID: 32289294 Free article. Clinical Trial.
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy.
van Rijssen TJ, van Dijk EHC, Dijkman G, Tsonaka R, Scholz P, Breukink MB, Hoyng CB, Peters PJH, MacLaren RE, Downes SM, Fauser S, Boon CJF. van Rijssen TJ, et al. Among authors: tsonaka r. Am J Ophthalmol. 2021 Feb;222:397-398. doi: 10.1016/j.ajo.2020.10.005. Epub 2020 Nov 12. Am J Ophthalmol. 2021. PMID: 33188739 No abstract available.
Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Dijkman G, Peters PJH, Tsonaka R, Keunen JEE, MacLaren RE, Hoyng CB, Downes SM, Fauser S, Boon CJF. van Rijssen TJ, et al. Among authors: tsonaka r. Acta Ophthalmol. 2021 Nov;99(7):805-811. doi: 10.1111/aos.14775. Epub 2021 Feb 10. Acta Ophthalmol. 2021. PMID: 33565230 Free PMC article. Clinical Trial.
RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
van Rijssen TJ, Hahn LC, van Dijk EHC, Tsonaka R, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF. van Rijssen TJ, et al. Among authors: tsonaka r. Retina. 2021 Oct 1;41(10):2122-2131. doi: 10.1097/IAE.0000000000003157. Retina. 2021. PMID: 34543244 Clinical Trial.
EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Feenstra HMA, Hahn LC, van Rijssen TJ, Tsonaka R, Breukink MB, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Fauser S, Hoyng CB, van Dijk EHC, Boon CJF. Feenstra HMA, et al. Among authors: tsonaka r. Retina. 2022 Apr 1;42(4):721-729. doi: 10.1097/IAE.0000000000003363. Retina. 2022. PMID: 34864802 Clinical Trial.
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3.
Feenstra HMA, van Dijk EHC, van Rijssen TJ, Tsonaka R, Diederen RMH, Hoyng CB, Schlingemann RO, Boon CJF. Feenstra HMA, et al. Among authors: tsonaka r. Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):659-668. doi: 10.1007/s00417-022-05836-x. Epub 2022 Oct 7. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36202933 Free PMC article. Clinical Trial.
Systemic complement activation in central serous chorioretinopathy.
van Dijk EHC, Tsonaka R, Klar-Mohamad N, Wouters D, de Vries APJ, de Jong EK, van Kooten C, Boon CJF. van Dijk EHC, et al. Among authors: tsonaka r. PLoS One. 2017 Jul 3;12(7):e0180312. doi: 10.1371/journal.pone.0180312. eCollection 2017. PLoS One. 2017. PMID: 28671968 Free PMC article.
The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy.
Brinks J, van Dijk EHC, Habeeb M, Nikolaou A, Tsonaka R, Peters HAB, Sips HCM, van de Merbel AF, de Jong EK, Notenboom RGE, Kielbasa SM, van der Maarel SM, Quax PHA, Meijer OC, Boon CJF. Brinks J, et al. Among authors: tsonaka r. Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5682-5692. doi: 10.1167/iovs.18-25054. Invest Ophthalmol Vis Sci. 2018. PMID: 30489628
83 results